Clinical Trials
Song-making In a Group (SING)
- Myeloma
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
- Phase 1 Cancers
Phase 1b/2 Study of ATR InhibiTor RP-3500 and PARP Inhibitor Combinations in Patients With Molecularly Selected Cancers (ATTACC)
- Leukemia
test
- Brain and Other Nervous System Cancers
test
- Prostate Cancer, Phase 1 Cancers
test
- Ages18 years and older
- GenderMale only
- Phase 1 Cancers
test
- Phase 1 Cancers
test
- Other Cancers
test
- Ages18 years and older
- GenderBoth
- Phase 1 Cancers
test